|
Serious adverse events
|
TR1_LY2484595-130mg |
TR2_PLACEBO |
|
Total subjects affected by serious adverse events
|
|
|
|
subjects affected / exposed
|
2306 / 6036 (38.20%) |
2341 / 6052 (38.68%) |
|
number of deaths (all causes)
|
240 |
287 |
|
number of deaths resulting from adverse events
|
8 |
5 |
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
|
acute myeloid leukaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
adenocarcinoma gastric
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
adenocarcinoma of colon
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adenocarcinoma pancreas
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adenosquamous cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
anal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaplastic astrocytoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
b-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
b-cell lymphoma stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
basal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
17 / 6036 (0.28%) |
13 / 6052 (0.21%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
basosquamous carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign gastric neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign neoplasm of adrenal gland
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign neoplasm of spinal cord
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign neoplasm of thyroid gland
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign renal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder transitional cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
borderline mucinous tumour of ovary
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bowen's disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchial carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
bronchial neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
burkitt's lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
buschke-lowenstein's tumour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carcinoid tumour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carcinoid tumour of the gastrointestinal tract
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervix carcinoma stage 0
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [1]
|
1 / 1388 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangiocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
chronic lymphocytic leukaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic lymphocytic leukaemia stage 0
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic myeloid leukaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon adenoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
1 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
colon cancer stage 0
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer stage iii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon cancer stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colorectal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colorectal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colorectal cancer stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
desmoplastic melanoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diffuse large b-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diffuse large b-cell lymphoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
diffuse large b-cell lymphoma stage ii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diffuse large b-cell lymphoma stage iii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endometrial adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ewing's sarcoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fallopian tube cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [2]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fibrous histiocytoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric adenoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
2 / 5 |
1 / 7 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 2 |
|
gastrointestinal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal stromal tumour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal tract adenoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrooesophageal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
gingival cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glioblastoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
haemangioma of liver
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hepatic cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hepatocellular carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hodgkin's disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hodgkin's disease stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
invasive breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
invasive ductal breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
invasive lobular breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
kaposi's sarcoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
keratinising squamous cell carcinoma of nasopharynx
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
keratoacanthoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestine benign neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laryngeal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laryngeal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laryngeal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lip squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lipoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
lung adenocarcinoma stage i
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung adenocarcinoma stage ii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung adenocarcinoma stage iii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
lung carcinoma cell type unspecified recurrent
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung carcinoma cell type unspecified stage ii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung carcinoma cell type unspecified stage iii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung carcinoma cell type unspecified stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
lung neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
14 / 6036 (0.23%) |
13 / 6052 (0.21%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
1 / 13 |
|
deaths causally related to treatment / all
|
0 / 7 |
1 / 8 |
|
lung squamous cell carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung squamous cell carcinoma stage i
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung squamous cell carcinoma stage iii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphocytic lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
malignant fibrous histiocytoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant melanoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant melanoma in situ
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant neoplasm of unknown primary site
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant neoplasm progression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
malignant pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mediastinum neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meningioma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meningioma malignant
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
metastases to bone
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to central nervous system
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
metastases to liver
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to lung
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to lymph nodes
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastases to salivary gland
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metastatic malignant melanoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
metastatic squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myelodysplastic syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
myxofibrosarcoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nasal sinus cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nasopharyngeal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neoplasm progression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neoplasm prostate
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [3]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neoplasm skin
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuroendocrine carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
neuroendocrine tumour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
non-hodgkin's lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-small cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
non-small cell lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
non-small cell lung cancer stage iii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-small cell lung cancer stage iiia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-small cell lung cancer stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
oesophageal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
oesophageal adenocarcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
2 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
|
oesophageal adenocarcinoma stage 0
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
oral cavity cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oropharyngeal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oropharyngeal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
1 / 8 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
pancreatic carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
pancreatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic neuroendocrine tumour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
papillary cystadenoma lymphomatosum
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
papillary thyroid cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parathyroid tumour benign
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
phaeochromocytoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pituitary tumour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
plasma cell myeloma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
polycythaemia vera
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [4]
|
26 / 4648 (0.56%) |
28 / 4658 (0.60%) |
|
occurrences causally related to treatment / all
|
0 / 26 |
0 / 28 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [5]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [6]
|
3 / 4648 (0.06%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate cancer stage ii
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [7]
|
2 / 4648 (0.04%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate cancer stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [8]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatic adenoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [9]
|
1 / 4648 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
rectal cancer stage 0
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
renal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
sinonasal papilloma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
small cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
small cell lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
spinal cord neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of lung
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
squamous cell carcinoma of skin
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of the oral cavity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
squamous cell carcinoma of the tongue
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
squamous cell carcinoma of the vulva
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
t-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
testicular neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [10]
|
1 / 4648 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
testicular seminoma (pure)
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [11]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
throat cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
thymoma malignant
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroid cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroid neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue carcinoma stage iv
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue neoplasm malignant stage unspecified
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tonsil cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tonsil cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transitional cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transitional cell carcinoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteric cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine cancer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [12]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
uterine leiomyoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [13]
|
1 / 1388 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine neoplasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [14]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Vascular disorders
|
|
|
|
accelerated hypertension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aneurysm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic aneurysm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
18 / 6036 (0.30%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic aneurysm rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
aortic dissection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic elongation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
aortic stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
18 / 6036 (0.30%) |
17 / 6052 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
aortitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial insufficiency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial occlusive disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
artery dissection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
axillary vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood pressure inadequately controlled
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brachiocephalic artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
circulatory collapse
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deep vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
16 / 6052 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
1 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dry gangrene
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
embolism arterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extremity necrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femoral artery aneurysm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femoral artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femoral artery perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
21 / 6036 (0.35%) |
18 / 6052 (0.30%) |
|
occurrences causally related to treatment / all
|
1 / 23 |
2 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive crisis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
1 / 9 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive emergency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypotension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
17 / 6052 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypovolaemic shock
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
iliac artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iliac artery rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intermittent claudication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
16 / 6052 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 20 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jugular vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphatic fistula
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphorrhoea
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malignant hypertension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
orthostatic hypotension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 11 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral arterial occlusive disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
52 / 6036 (0.86%) |
50 / 6052 (0.83%) |
|
occurrences causally related to treatment / all
|
0 / 66 |
1 / 66 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
peripheral artery aneurysm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
19 / 6036 (0.31%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 21 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral embolism
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral ischaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
12 / 6036 (0.20%) |
20 / 6052 (0.33%) |
|
occurrences causally related to treatment / all
|
0 / 14 |
0 / 25 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
peripheral vascular disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
21 / 6036 (0.35%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 25 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
shock
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
shock haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
subclavian artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subclavian artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subclavian artery thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
temporal arteritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombophlebitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombophlebitis superficial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
varicose vein
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vasculitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vena cava thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
venous thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
venous thrombosis limb
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Surgical and medical procedures
|
|
|
|
abdominal hernia repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adrenalectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
amputation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
analgesic therapy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aneurysm repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
angioplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
12 / 6036 (0.20%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ankle arthroplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic aneurysm repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic bypass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic valve repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic valve replacement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arterial stent insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atherectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial septal defect repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
autonomic nerve operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder neck suspension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [15]
|
1 / 1388 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bone operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchial lesion excision
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cancer surgery
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac ablation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac pacemaker battery replacement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac pacemaker insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac pacemaker replacement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac rehabilitation therapy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac resynchronisation therapy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardioversion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid angioplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid endarterectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid revascularisation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carpal tunnel decompression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
catheter placement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colostomy closure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary angioplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
13 / 6036 (0.22%) |
21 / 6052 (0.35%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 23 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary arterial stent insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
12 / 6052 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery bypass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
54 / 6036 (0.89%) |
59 / 6052 (0.97%) |
|
occurrences causally related to treatment / all
|
0 / 54 |
0 / 59 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary revascularisation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
82 / 6036 (1.36%) |
79 / 6052 (1.31%) |
|
occurrences causally related to treatment / all
|
0 / 92 |
0 / 89 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cox-maze procedure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
debridement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diaphragmatic operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
elective surgery
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endarterectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endovenous ablation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
explorative laparotomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
exploratory operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eye operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foot amputation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric bypass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal endoscopic therapy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematoma evacuation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heart valve replacement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hernia repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
high frequency ablation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hip arthroplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hip surgery
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hospitalisation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hysterectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [16]
|
1 / 1388 (0.07%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
implantable defibrillator insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
13 / 6052 (0.21%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
implantable defibrillator replacement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incisional drainage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incisional hernia repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
inguinal hernia repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intraocular lens implant
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint arthroplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
knee arthroplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
12 / 6036 (0.20%) |
12 / 6052 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 14 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
knee operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
leg amputation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lens extraction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lipoma excision
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mastectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
medical device change
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
medical device removal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve replacement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephrectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
open reduction of fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteosynthesis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteotomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreaticoduodenectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
penile repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [17]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
percutaneous coronary intervention
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
192 / 6036 (3.18%) |
182 / 6052 (3.01%) |
|
occurrences causally related to treatment / all
|
1 / 217 |
1 / 214 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery angioplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery bypass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 5 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery stent insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral endarterectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral nerve transposition
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral revascularisation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostate ablation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [18]
|
0 / 6036 (0.00%) |
2 / 4658 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radioactive iodine therapy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal prolapse repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal artery angioplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal sympathetic nerve ablation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
resection of rectum
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
resuscitation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinopexy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rotator cuff repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
shoulder arthroplasty
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
shoulder operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin neoplasm excision
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal decompression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal fusion surgery
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal laminectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stent placement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sympathectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tenotomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
therapeutic embolisation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
therapy cessation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombosis prophylaxis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thyroidectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
toe amputation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue operation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
total adrenalectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transmyocardial revascularisation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transurethral bladder resection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transurethral prostatectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [19]
|
2 / 4648 (0.04%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tricuspid valve repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tumour excision
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteral stent insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteral stent removal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vaginal prolapse repair
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [20]
|
1 / 1388 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
valvuloplasty cardiac
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular graft
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
venous stent insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular assist device insertion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vitrectomy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound drainage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Pregnancy, puerperium and perinatal conditions
|
|
|
|
abortion spontaneous
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [21]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pregnancy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [22]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
General disorders and administration site conditions
|
|
|
|
adverse drug reaction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
asthenia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
2 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac death
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 5 |
|
chest discomfort
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
12 / 6052 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
2 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chest pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
37 / 6036 (0.61%) |
34 / 6052 (0.56%) |
|
occurrences causally related to treatment / all
|
3 / 38 |
0 / 42 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
death
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
20 / 6036 (0.33%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
2 / 20 |
0 / 14 |
|
deaths causally related to treatment / all
|
2 / 20 |
0 / 14 |
|
device breakage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device dislocation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device end of service
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device inappropriate shock delivery
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device malfunction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device material issue
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
drowning
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
drug withdrawal syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
exercise tolerance decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gait disturbance
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
general physical health deterioration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
generalised oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
granuloma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperthermia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertrophy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypothermia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
impaired healing
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
implant site haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incarcerated hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lead dislodgement
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
multi-organ failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
necrobiosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
necrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
non-cardiac chest pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
107 / 6036 (1.77%) |
108 / 6052 (1.78%) |
|
occurrences causally related to treatment / all
|
1 / 123 |
1 / 118 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oedema peripheral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic mass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral swelling
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
precancerous mucosal lesion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyrexia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stent-graft endoleak
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sudden cardiac death
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
16 / 6036 (0.27%) |
15 / 6052 (0.25%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 16 |
0 / 15 |
|
sudden death
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
systemic inflammatory response syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombosis in device
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular stent occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular stent restenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular stent stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular stent thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vessel puncture site haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Immune system disorders
|
|
|
|
anaphylactic reaction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaphylactic shock
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
drug hypersensitivity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypersensitivity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Reproductive system and breast disorders
|
|
|
|
amastia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
benign prostatic hyperplasia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [23]
|
10 / 4648 (0.22%) |
12 / 4658 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
cervical polyp
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [24]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystocele
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [25]
|
1 / 1388 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysmenorrhoea
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [26]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
menometrorrhagia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [27]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ovarian cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [28]
|
2 / 1388 (0.14%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
penile necrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [29]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peyronie's disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [30]
|
1 / 4648 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [31]
|
4 / 4648 (0.09%) |
2 / 4658 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectocele
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [32]
|
0 / 6036 (0.00%) |
1 / 1394 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
testicular disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [33]
|
1 / 4648 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine polyp
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [34]
|
1 / 1388 (0.07%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uterine prolapse
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [35]
|
2 / 1388 (0.14%) |
2 / 1394 (0.14%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Respiratory, thoracic and mediastinal disorders
|
|
|
|
acute pulmonary oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
acute respiratory distress syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
acute respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
14 / 6036 (0.23%) |
20 / 6052 (0.33%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 20 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
alveolitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
asphyxia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
aspiration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
asthma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atelectasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchiectasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis chronic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchospasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic obstructive pulmonary disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
43 / 6036 (0.71%) |
47 / 6052 (0.78%) |
|
occurrences causally related to treatment / all
|
0 / 55 |
0 / 55 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
chylothorax
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cough
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dyspnoea
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
26 / 6036 (0.43%) |
23 / 6052 (0.38%) |
|
occurrences causally related to treatment / all
|
0 / 29 |
0 / 23 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dyspnoea exertional
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
emphysema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
epistaxis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemoptysis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemothorax
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hiccups
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydrothorax
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypercapnia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoxia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
idiopathic pulmonary fibrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
interstitial lung disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung consolidation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung infiltration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mediastinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
nasal septum deviation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
organising pneumonia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pickwickian syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
12 / 6052 (0.20%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 13 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
pleurisy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pleuritic pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumomediastinum
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia aspiration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
pneumonitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumothorax
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumothorax spontaneous
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary alveolar haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary arterial hypertension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary congestion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary embolism
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
21 / 6036 (0.35%) |
20 / 6052 (0.33%) |
|
occurrences causally related to treatment / all
|
1 / 22 |
1 / 20 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
pulmonary fibrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
pulmonary hypertension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary mass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
pulmonary oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory arrest
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
respiratory distress
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
17 / 6036 (0.28%) |
16 / 6052 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
sleep apnoea syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tracheomalacia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Psychiatric disorders
|
|
|
|
abnormal behaviour
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acute psychosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acute stress disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adjustment disorder with anxiety
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adjustment disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adjustment disorder with depressed mood
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
adjustment disorder with mixed disturbance of emotion and conduct
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aggression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcohol abuse
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcohol withdrawal syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcoholism
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anxiety
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anxiety disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
completed suicide
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
confusional state
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
delirium
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
delirium tremens
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
depression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
depression suicidal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
generalised anxiety disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hallucination
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypomania
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
major depression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mental disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mental status changes
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
13 / 6052 (0.21%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
panic attack
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post-traumatic stress disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psychogenic seizure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psychotic disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
suicidal ideation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
suicide attempt
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Hepatobiliary disorders
|
|
|
|
autoimmune hepatitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
bile duct stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bile duct stone
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary colic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary tract disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangitis acute
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
19 / 6036 (0.31%) |
16 / 6052 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
1 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis acute
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
12 / 6036 (0.20%) |
15 / 6052 (0.25%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis chronic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholelithiasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
23 / 6036 (0.38%) |
22 / 6052 (0.36%) |
|
occurrences causally related to treatment / all
|
0 / 23 |
1 / 23 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholestasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic cirrhosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
hepatic lesion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic steatosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis alcoholic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatomegaly
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydrocholecystis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic hepatitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaundice
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaundice cholestatic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaundice extrahepatic obstructive
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
liver disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
liver injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
portal vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Investigations
|
|
|
|
alanine aminotransferase increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
angiogram
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anticoagulation drug level above therapeutic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriogram
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriogram coronary
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
16 / 6036 (0.27%) |
17 / 6052 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 17 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriogram renal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aspartate aminotransferase increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biopsy brain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood creatine phosphokinase increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood creatinine increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood glucose decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood glucose increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood osmolarity decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
blood pressure increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac function test
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac stress test abnormal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiovascular evaluation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiovascular examination
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid bruit
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
catheterisation cardiac
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
10 / 6036 (0.17%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium test positive
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colonoscopy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
computerised tomogram
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
computerised tomogram thorax
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diagnostic procedure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ejection fraction decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
electrocardiogram abnormal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
electrocardiogram qt prolonged
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endoscopy gastrointestinal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gamma-glutamyltransferase increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemoglobin decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heart rate irregular
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatic enzyme increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
international normalised ratio decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
international normalised ratio increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
investigation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
liver function test abnormal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myocardial necrosis marker increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophagogastroduodenoscopy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral arteriogram
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prostatic specific antigen increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [36]
|
2 / 4648 (0.04%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transaminases increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
troponin increased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteroscopy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vitamin b12 decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
weight decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Injury, poisoning and procedural complications
|
|
|
|
abdominal wound dehiscence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
accident
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
accidental exposure to product
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
accidental overdose
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acetabulum fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcohol poisoning
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anaemia postoperative
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anastomotic stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anastomotic ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ankle fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
back injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain contusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cartilage injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
chemical burn of skin
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chemical injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chest injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clavicle fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colon injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
compression fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
concussion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
contrast media reaction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
contusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery restenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
craniocerebral injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
crush injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystitis radiation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extradural haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eye injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
facial bones fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fall
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
39 / 6036 (0.65%) |
50 / 6052 (0.83%) |
|
occurrences causally related to treatment / all
|
0 / 40 |
0 / 53 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femoral neck fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femur fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fibula fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foot fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foreign body
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fractured sacrum
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal anastomotic complication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal stoma complication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
graft thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gun shot wound
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
hand fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
head injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heat illness
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hip fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
humerus fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incisional hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intentional overdose
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jaw fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint dislocation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
laceration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ligament injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ligament sprain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
limb traumatic amputation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower limb fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbar vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meniscus injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
multiple fractures
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
multiple injuries
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
muscle contusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nerve root injury lumbar
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
overdose
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
patella fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral arterial reocclusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peripheral artery restenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
periprosthetic fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
poisoning
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post concussion syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post laminectomy syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural bile leak
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural complication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative fever
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative ileus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative thoracic procedure complication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative wound complication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
procedural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
procedural hypotension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pubis fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary contusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radius fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rib fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
road traffic accident
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
15 / 6036 (0.25%) |
15 / 6052 (0.25%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
seroma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skull fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
soft tissue injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal compression fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord injury cervical
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
splenic rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sternal fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stoma site haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subdural haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
subdural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
tendon injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendon rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thermal burn
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thoracic vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tibia fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tooth fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
toxicity to various agents
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
traumatic amputation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
traumatic intracranial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
traumatic liver injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ulna fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
upper limb fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular graft occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular graft thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular pseudoaneurysm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular pseudoaneurysm ruptured
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
wound
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound complication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound dehiscence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wrist fracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Congenital, familial and genetic disorders
|
|
|
|
arteriovenous malformation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial septal defect
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dermoid cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydrocele
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [37]
|
0 / 6036 (0.00%) |
2 / 4658 (0.04%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertrophic cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
leukodystrophy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
phimosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [38]
|
0 / 6036 (0.00%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Cardiac disorders
|
|
|
|
acute coronary syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
acute myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
146 / 6036 (2.42%) |
137 / 6052 (2.26%) |
|
occurrences causally related to treatment / all
|
5 / 168 |
4 / 149 |
|
deaths causally related to treatment / all
|
0 / 16 |
0 / 4 |
|
adams-stokes syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
angina pectoris
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
102 / 6036 (1.69%) |
98 / 6052 (1.62%) |
|
occurrences causally related to treatment / all
|
3 / 113 |
3 / 103 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
angina unstable
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
298 / 6036 (4.94%) |
289 / 6052 (4.78%) |
|
occurrences causally related to treatment / all
|
7 / 389 |
6 / 363 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
aortic valve disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
aortic valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic valve sclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aortic valve stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
arteriosclerosis coronary artery
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriospasm coronary
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial flutter
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
25 / 6036 (0.41%) |
16 / 6052 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 27 |
1 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial fibrillation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
86 / 6036 (1.42%) |
78 / 6052 (1.29%) |
|
occurrences causally related to treatment / all
|
1 / 109 |
2 / 94 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial tachycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrial thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrioventricular block
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atrioventricular block complete
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
atrioventricular block second degree
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bradyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bradycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
11 / 6052 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac arrest
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
17 / 6036 (0.28%) |
30 / 6052 (0.50%) |
|
occurrences causally related to treatment / all
|
1 / 18 |
0 / 32 |
|
deaths causally related to treatment / all
|
1 / 12 |
0 / 21 |
|
cardiac discomfort
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardiac failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
67 / 6036 (1.11%) |
63 / 6052 (1.04%) |
|
occurrences causally related to treatment / all
|
1 / 79 |
1 / 78 |
|
deaths causally related to treatment / all
|
0 / 9 |
0 / 8 |
|
cardiac failure acute
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
cardiac failure chronic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
cardiac failure congestive
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
95 / 6036 (1.57%) |
103 / 6052 (1.70%) |
|
occurrences causally related to treatment / all
|
1 / 134 |
0 / 138 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 12 |
|
cardiac tamponade
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cardio-respiratory arrest
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
2 / 7 |
|
deaths causally related to treatment / all
|
0 / 3 |
1 / 5 |
|
cardiogenic shock
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
1 / 8 |
0 / 7 |
|
deaths causally related to treatment / all
|
1 / 4 |
0 / 4 |
|
cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
cardiopulmonary failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
cardiorenal syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
cardiovascular insufficiency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronotropic incompetence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
conduction disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
congestive cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
coronary artery disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
37 / 6036 (0.61%) |
44 / 6052 (0.73%) |
|
occurrences causally related to treatment / all
|
1 / 40 |
2 / 45 |
|
deaths causally related to treatment / all
|
0 / 3 |
1 / 4 |
|
coronary artery dissection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coronary artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diastolic dysfunction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dressler's syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypertensive heart disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intracardiac thrombus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
left ventricular dysfunction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
left ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
microvascular coronary artery disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mitral valve stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
82 / 6036 (1.36%) |
100 / 6052 (1.65%) |
|
occurrences causally related to treatment / all
|
1 / 88 |
0 / 107 |
|
deaths causally related to treatment / all
|
0 / 14 |
0 / 17 |
|
myocardial ischaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
15 / 6036 (0.25%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
1 / 16 |
1 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
myocardial rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
nodal rhythm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
palpitations
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pericardial effusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pericardial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
pericarditis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postinfarction angina
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prinzmetal angina
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
right ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
sinus arrest
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus bradycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus node dysfunction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
12 / 6036 (0.20%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinus tachycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stress cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
supraventricular tachycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
systolic dysfunction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tachyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tachycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricle rupture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
ventricular extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular fibrillation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
ventricular hypokinesia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular tachyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ventricular tachycardia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
16 / 6036 (0.27%) |
24 / 6052 (0.40%) |
|
occurrences causally related to treatment / all
|
0 / 21 |
0 / 24 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wolff-parkinson-white syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Nervous system disorders
|
|
|
|
acute disseminated encephalomyelitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
amyotrophic lateral sclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aphasia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ataxia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
autonomic nervous system imbalance
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
brain injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
brain mass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
brain stem stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid artery disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
21 / 6036 (0.35%) |
39 / 6052 (0.64%) |
|
occurrences causally related to treatment / all
|
0 / 21 |
0 / 42 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carotid sinus syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
carpal tunnel syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebellar ischaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebellar syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
2 / 5 |
1 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebral ischaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cerebrovascular accident
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
61 / 6036 (1.01%) |
62 / 6052 (1.02%) |
|
occurrences causally related to treatment / all
|
0 / 63 |
0 / 65 |
|
deaths causally related to treatment / all
|
0 / 7 |
0 / 10 |
|
cerebrovascular insufficiency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
cervical myelopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cognitive disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
complex partial seizures
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
complex regional pain syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dementia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dementia alzheimer's type
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
diabetic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dizziness
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
embolic cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
embolic stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
epilepsy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
essential tremor
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
guillain-barre syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhage intracranial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
haemorrhagic stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
haemorrhagic transformation stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
headache
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hemiparesis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoaesthesia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoglycaemic coma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoxic-ischaemic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
intraventricular haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ischaemic stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
25 / 6036 (0.41%) |
18 / 6052 (0.30%) |
|
occurrences causally related to treatment / all
|
1 / 25 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
lacunar infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
loss of consciousness
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbar radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbosacral radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metabolic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
migraine
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
moyamoya disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myasthenia gravis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myelitis transverse
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myoclonus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nerve compression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nerve root compression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nervous system disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuralgia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuropathy peripheral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
normal pressure hydrocephalus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
paraesthesia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parkinson's disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
partial seizures
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peroneal nerve palsy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
polyneuropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post herpetic neuralgia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postictal paralysis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
presyncope
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
quadriparesis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
quadriplegia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radicular syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
restless legs syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sciatica
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
seizure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal claudication
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord compression
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
status epilepticus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subarachnoid haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
syncope
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
46 / 6036 (0.76%) |
52 / 6052 (0.86%) |
|
occurrences causally related to treatment / all
|
0 / 48 |
1 / 54 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thalamus haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombotic stroke
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
toxic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transient global amnesia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
transient ischaemic attack
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
37 / 6036 (0.61%) |
39 / 6052 (0.64%) |
|
occurrences causally related to treatment / all
|
1 / 44 |
0 / 42 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tremor
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
trigeminal neuralgia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
uraemic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular dementia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vascular encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vasogenic cerebral oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertebral artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertebrobasilar insufficiency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertigo cns origin
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
viith nerve paralysis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vith nerve paralysis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vith nerve paresis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Blood and lymphatic system disorders
|
|
|
|
anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
30 / 6036 (0.50%) |
38 / 6052 (0.63%) |
|
occurrences causally related to treatment / all
|
0 / 31 |
2 / 46 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
aplastic anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
coagulopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cytopenia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
disseminated intravascular coagulation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
febrile neutropenia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhagic anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heparin-induced thrombocytopenia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
immune thrombocytopenic purpura
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iron deficiency anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
leukocytosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphadenitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphadenopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lymphadenopathy mediastinal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
microcytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
normochromic normocytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancytopenia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pernicious anaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
splenic infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spontaneous haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
thrombocytopenia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Ear and labyrinth disorders
|
|
|
|
conductive deafness
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
deafness neurosensory
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ear pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eustachian tube dysfunction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
meniere's disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
otosclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tinnitus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertigo
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
15 / 6052 (0.25%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertigo positional
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Eye disorders
|
|
|
|
age-related macular degeneration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
15 / 6036 (0.25%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 19 |
2 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cataract nuclear
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
conjunctival haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic retinopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diplopia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ectropion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
entropion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eye haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eye pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
eyelid ptosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glaucoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
idiopathic orbital inflammation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iridocyclitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
iritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
keratitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
keratopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lens dislocation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
macular fibrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
open angle glaucoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
optic atrophy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
optic ischaemic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
optic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal detachment
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retinopathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
visual acuity reduced
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
visual impairment
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vitreous haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Gastrointestinal disorders
|
|
|
|
abdominal adhesions
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal compartment syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal distension
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal mass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
18 / 6036 (0.30%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal pain upper
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal strangulated hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal wall cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal wall haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
alcoholic pancreatitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ascites
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic gastritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
coeliac artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
colitis ischaemic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
2 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis microscopic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colitis ulcerative
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colonic fistula
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
constipation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
crohn's disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diarrhoea
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dieulafoy's vascular malformation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticular perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulum
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulum intestinal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulum intestinal haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenal stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenal ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenal ulcer perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
duodenitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dyspepsia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysphagia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enteritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterocolitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterovesical fistula
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erosive oesophagitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
faecal incontinence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
faecaloma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
femoral hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
food poisoning
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric polyps
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
10 / 6036 (0.17%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastric ulcer perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis alcoholic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis erosive
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
gastrointestinal angiodysplasia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal angiodysplasia haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
32 / 6036 (0.53%) |
26 / 6052 (0.43%) |
|
occurrences causally related to treatment / all
|
1 / 32 |
0 / 32 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
gastrointestinal inflammation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrointestinal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastrooesophageal reflux disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
13 / 6036 (0.22%) |
11 / 6052 (0.18%) |
|
occurrences causally related to treatment / all
|
1 / 13 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gingival bleeding
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glossitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematemesis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
haematochezia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhoidal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemorrhoids
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
heyde's syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hiatus hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ileus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
impaired gastric emptying
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
inguinal hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
15 / 6036 (0.25%) |
13 / 6052 (0.21%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal infarction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal ischaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intestinal perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
intestinal prolapse
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intra-abdominal haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intra-abdominal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
irritable bowel syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
jejunal perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestine perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
large intestine polyp
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
11 / 6052 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
1 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
localised intraabdominal fluid collection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mallory-weiss syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
melaena
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mesenteric vascular insufficiency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mouth haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nausea
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
1 / 8 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
odynophagia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oedematous pancreatitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal achalasia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal spasm
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophagitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic mass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatic pseudocyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
12 / 6036 (0.20%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
1 / 13 |
2 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis acute
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
10 / 6036 (0.17%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis chronic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pancreatitis necrotising
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peptic ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peptic ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritoneal adhesions
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumoperitoneum
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal polyp
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rectal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
retroperitoneal effusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retroperitoneal haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
retroperitoneal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
salivary gland mass
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
small intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
small intestinal perforation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subileus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
swollen tongue
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tongue oedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
umbilical hernia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
upper gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 12 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
volvulus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vomiting
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
1 / 12 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Skin and subcutaneous tissue disorders
|
|
|
|
angioedema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
decubitus ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dermal cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dermatomyositis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic foot
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
10 / 6036 (0.17%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic neuropathic ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erythema multiforme
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
henoch-schonlein purpura
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperhidrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperkeratosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypersensitivity vasculitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
psoriasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rash
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin lesion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
1 / 9 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urticaria
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vasculitic rash
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Renal and urinary disorders
|
|
|
|
acute kidney injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
48 / 6036 (0.80%) |
67 / 6052 (1.11%) |
|
occurrences causally related to treatment / all
|
0 / 58 |
2 / 81 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
acute prerenal failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
azotaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder outlet obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bladder prolapse
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
calculus ureteric
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
calculus urinary
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic kidney disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
1 / 10 |
3 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
cystitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystitis ulcerative
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic nephropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dysuria
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glomerulonephritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
glomerulosclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematuria
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 14 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hydronephrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypotonic urinary bladder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephrolithiasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
19 / 6036 (0.31%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 20 |
0 / 12 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephrosclerosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nephrotic syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
obstructive uropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvi-ureteric obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
prerenal failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal colic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal failure
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
14 / 6036 (0.23%) |
11 / 6052 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 16 |
0 / 11 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
renal haematoma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal impairment
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
renal infarct
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal injury
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal tubular necrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
renal vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
stress urinary incontinence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tubulointerstitial nephritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ureteral disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urethral haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urethral stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary bladder haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary incontinence
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary retention
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary tract obstruction
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Endocrine disorders
|
|
|
|
autoimmune thyroiditis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
goitre
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperparathyroidism
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperparathyroidism primary
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Musculoskeletal and connective tissue disorders
|
|
|
|
ankylosing spondylitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthralgia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
17 / 6052 (0.28%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 19 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
back pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
15 / 6036 (0.25%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bone pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bursitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cervical spinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chondrocalcinosis pyrophosphate
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
compartment syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
costochondritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dupuytren's contracture
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
facet joint syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
fibromyalgia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
foot deformity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gouty arthritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
groin pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haemarthrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc degeneration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral disc protrusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint instability
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
joint swelling
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
kyphosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ligament laxity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lumbar spinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
13 / 6036 (0.22%) |
23 / 6052 (0.38%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
1 / 24 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mobility decreased
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscle spasms
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
muscular weakness
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
musculoskeletal chest pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
17 / 6036 (0.28%) |
15 / 6052 (0.25%) |
|
occurrences causally related to treatment / all
|
0 / 18 |
0 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
musculoskeletal discomfort
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
musculoskeletal pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
musculoskeletal stiffness
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myalgia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neck pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
neuropathic arthropathy
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
osteoarthritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
70 / 6036 (1.16%) |
66 / 6052 (1.09%) |
|
occurrences causally related to treatment / all
|
0 / 76 |
1 / 75 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteochondrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteonecrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pain in extremity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
2 / 7 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pain in jaw
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
polymyalgia rheumatica
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pseudarthrosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rhabdomyolysis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
1 / 6 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rheumatoid arthritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rotator cuff syndrome
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
scoliosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal column stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
spinal osteoarthritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal pain
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spondylolisthesis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
synovial cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
synovitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendon disorder
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tendonitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
trigger finger
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vertebral foraminal stenosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Infections and infestations
|
|
|
|
abdominal abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
abdominal wall abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abdominal wall infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess limb
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess neck
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess of salivary gland
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
abscess oral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
acute sinusitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
anal abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
appendicitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
appendicitis perforated
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteriosclerotic gangrene
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arteritis infective
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
arthritis bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
atypical pneumonia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bacterial infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bacterial sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
biliary tract infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
breast cellulitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
25 / 6036 (0.41%) |
18 / 6052 (0.30%) |
|
occurrences causally related to treatment / all
|
0 / 25 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bronchitis viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
bursitis infective
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cellulitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
41 / 6036 (0.68%) |
42 / 6052 (0.69%) |
|
occurrences causally related to treatment / all
|
0 / 48 |
0 / 45 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cellulitis staphylococcal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholangitis infective
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cholecystitis infective
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
chronic sinusitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium difficile colitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
8 / 6052 (0.13%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium difficile infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
clostridium difficile sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
colonic abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
cystitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
device related infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic foot infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic gangrene
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diverticulitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
13 / 6036 (0.22%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endocarditis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endocarditis bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endocarditis enterococcal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
endophthalmitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterobacter infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterococcal bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterococcal infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
enterococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
epididymitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [39]
|
1 / 4648 (0.02%) |
1 / 4658 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
erysipelas
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia pyelonephritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
escherichia urinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
extradural abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
febrile infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
folliculitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gallbladder empyema
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gangrene
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
11 / 6052 (0.18%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastritis viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
16 / 6036 (0.27%) |
16 / 6052 (0.26%) |
|
occurrences causally related to treatment / all
|
0 / 19 |
0 / 16 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis norovirus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gastroenteritis viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
giardiasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
graft infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
groin abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
h1n1 influenza
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
haematoma infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis c
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hepatitis viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
herpes zoster
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
implant site cellulitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
implant site infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
incision site infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infected bite
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infected fistula
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infected seroma
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infected skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infectious colitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infectious pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
infective exacerbation of chronic obstructive airways disease
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
influenza
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infusion site cellulitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
infusion site infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
intervertebral discitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
keratitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
klebsiella sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
liver abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
localised infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lower respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
lung abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lung infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mastoiditis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
mediastinitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
myelitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
nail bed infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
necrotising fasciitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
oesophageal candidiasis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
orbital infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
13 / 6036 (0.22%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 15 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis acute
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
osteomyelitis chronic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parainfluenzae virus infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parotitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
parvovirus infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pelvic abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
penile abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed [40]
|
1 / 4648 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
perihepatic abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
periodontitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
perirectal abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritonitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
peritonitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
peritonsillar abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pharyngitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pilonidal cyst
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
115 / 6036 (1.91%) |
112 / 6052 (1.85%) |
|
occurrences causally related to treatment / all
|
0 / 128 |
0 / 122 |
|
deaths causally related to treatment / all
|
0 / 7 |
0 / 4 |
|
pneumonia bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia chlamydial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia fungal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia influenzal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia legionella
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia parainfluenzae viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia pneumococcal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia staphylococcal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
pneumonia streptococcal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pneumonia viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural cellulitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
post procedural sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
postoperative wound infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pulmonary sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
pulmonary tuberculosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelonephritis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
7 / 6036 (0.12%) |
4 / 6052 (0.07%) |
|
occurrences causally related to treatment / all
|
1 / 7 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelonephritis acute
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
pyelonephritis chronic
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory syncytial virus infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
respiratory tract infection viral
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
rhinovirus infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
salmonellosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
44 / 6036 (0.73%) |
28 / 6052 (0.46%) |
|
occurrences causally related to treatment / all
|
0 / 49 |
0 / 32 |
|
deaths causally related to treatment / all
|
0 / 7 |
0 / 7 |
|
septic shock
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
10 / 6036 (0.17%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 10 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 4 |
0 / 3 |
|
sialoadenitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinusitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
sinusitis fungal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
skin candida
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
soft tissue infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
spinal cord abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
|
staphylococcal bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
staphylococcal infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal mediastinitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
staphylococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
streptococcal bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
streptococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
subcutaneous abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tooth infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
tracheobronchitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
upper respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
19 / 6036 (0.31%) |
32 / 6052 (0.53%) |
|
occurrences causally related to treatment / all
|
0 / 22 |
0 / 36 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
urinary tract infection bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urinary tract infection pseudomonal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
urosepsis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
16 / 6036 (0.27%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 17 |
0 / 14 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
vestibular neuronitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
viral infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
3 / 6052 (0.05%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
viral labyrinthitis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound abscess
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound infection
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 8 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound infection bacterial
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
wound infection staphylococcal
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
Metabolism and nutrition disorders
|
|
|
|
decreased appetite
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
dehydration
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
15 / 6036 (0.25%) |
26 / 6052 (0.43%) |
|
occurrences causally related to treatment / all
|
1 / 15 |
0 / 28 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
11 / 6036 (0.18%) |
20 / 6052 (0.33%) |
|
occurrences causally related to treatment / all
|
0 / 11 |
1 / 22 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetes mellitus inadequate control
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
8 / 6036 (0.13%) |
14 / 6052 (0.23%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
1 / 15 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic ketoacidosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
3 / 6036 (0.05%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
diabetic metabolic decompensation
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
electrolyte imbalance
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
failure to thrive
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
fluid overload
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
gout
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypercalcaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperglycaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
13 / 6036 (0.22%) |
10 / 6052 (0.17%) |
|
occurrences causally related to treatment / all
|
0 / 13 |
1 / 11 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyperkalaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
9 / 6036 (0.15%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 9 |
0 / 10 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
hyperosmolar hyperglycaemic state
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypoglycaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
17 / 6036 (0.28%) |
18 / 6052 (0.30%) |
|
occurrences causally related to treatment / all
|
1 / 17 |
0 / 18 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypokalaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
4 / 6036 (0.07%) |
7 / 6052 (0.12%) |
|
occurrences causally related to treatment / all
|
0 / 4 |
0 / 7 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypomagnesaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hyponatraemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
9 / 6052 (0.15%) |
|
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
hypovolaemia
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
2 / 6052 (0.03%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
ketoacidosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
lactic acidosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
malnutrition
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
1 / 6036 (0.02%) |
0 / 6052 (0.00%) |
|
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
metabolic acidosis
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
2 / 6036 (0.03%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
|
obesity
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
5 / 6036 (0.08%) |
5 / 6052 (0.08%) |
|
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
type 2 diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
6 / 6036 (0.10%) |
6 / 6052 (0.10%) |
|
occurrences causally related to treatment / all
|
4 / 6 |
2 / 6 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
|
vitamin b12 deficiency
|
|
|
|
alternative dictionary used: MedDRA
15.1
|
|
|
|
subjects affected / exposed
|
0 / 6036 (0.00%) |
1 / 6052 (0.02%) |
|
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
|
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |